Michael Burger, senior consultant at Point-of-Care Partners, explains that real-time benefit check lets physicians know how much a drug will cost the patient at the time they're writing the prescription, allowing them to give the patient a treatment they know they can afford.
At AMCP 2023, Michael Burger, senior consultant at Point-of-Care Partners, explained the important role real-time benefit check (RTBC) plays in the decision-making process.
What is real-time benefit check?
Real-time benefit check—also known as RTBC—is an electronic transaction, which is used to identify a patient's prescription benefit coverage and to identify what their out-of-pocket costs will be, as well as what any of the restrictions on that prescription might be, things like prior authorization. RTBC is available to the prescriber. So in the doctor's office at the point where the prescription is being written, information about what that prescription will cost the patient is available and it can be used as part of the decision making process to decide which drug to order for the patient.
How does RTBC encourage providers to consider costs when prescribing medications?
Prescription cost is something that is not especially transparent, it isn't uncommon for the patient to understand what the prescription will cost only when they get to the pharmacy counter. So sometimes that results in the patient not being able to afford the medication, or maybe being forced to pay for the medication and then not use it according to instructions. Maybe they cut a pill in half or they take it every other day.
So the idea behind RTBC is that the cost to the patient is known to the physician at the point where they're writing the prescription, so they can decide on the most cost effective drug, one that they know that the patient can afford, so that way they're sure that the patient gets on the therapy.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More